Race Against Time of Validation Study of Trisomy 21 Diagnostic Test II

Sequenom announced this week that they have entered into a supply agreement with Illumina for sequencing equipment and consumables. They will purchase the Illumina products for use in developing its non-invasive trisomy 21 test.

Sequenom plan to launch its SensiGene T21 test as a laboratory-developed test at the end of 2011 or in Q1 2012. The company also had previously disclosed that it had completed a validation study of its test on the Illumina HiSeq platform in 2,000 high-risk pregnancies, which will serve as the basis for the LDT.

It keeps exciting what GATC and Verinata are doing (resp. launching) in the meanwhile…

Carola Grimminger

About Carola Grimminger

New media trend scouting from a Marketing perspective. This is what Carola Grimminger stands for.

No comments yet... Be the first to leave a reply!